{"transactions":[{"id":737344,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-15T23:40:59.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in substantially equal monthly installments over the 12 months following June 15, 2026 (or, in the event the next annual meeting of the issuer's stockholders occurs prior to June 15, 2027, any remaining unvested portion of the stock option will vest on the date of such annual meeting), subject to the reporting person's continuing service on the issuer's board of directors through such vesting date."}],"balance_after":32000,"derivative":{"exercise_price":1.4,"expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001193125-26-271474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782303/000119312526271474/ownership.xml","form_type":"4"}},{"id":890214,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:28:13.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001880609-26-000002","document":"wk-form4_1771626490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000188060926000002/wk-form4_1771626490.xml","form_type":"4"}},{"id":1103417,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T21:09:35.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in substantially equal monthly installments over the 12 months following June 23, 2025 (or, in the event the next annual meeting of the issuer's stockholders occurs prior to June 23, 2026, any remaining unvested portion of the stock option will vest on the date of such annual meeting), subject to the reporting person's continuing service on the issuer's board of directors through such vesting date."}],"balance_after":16000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-06-22","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-089067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025089067/ownership.xml","form_type":"4"}},{"id":1252243,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:17:04.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001880609-25-000003","document":"wk-form4_1740187018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000188060925000003/wk-form4_1740187018.xml","form_type":"4"}},{"id":1557382,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-03-29T20:30:12.000Z","date":"2024-03-27","kind":"grant","planned":false,"acquired":true,"shares":13219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 36 substantially equal monthly installments beginning on April 27, 2024."}],"balance_after":13219,"derivative":{"exercise_price":16,"expiration_date":"2034-03-26","underlying":"Common Stock","underlying_shares":13219},"source":{"system":"sec-edgar","filing":"0000950170-24-038693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017024038693/ownership.xml","form_type":"4"}},{"id":1624586,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:10:50.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006414","document":"wk-form4_1708639829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006414/wk-form4_1708639829.xml","form_type":"4"}},{"id":1995274,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T21:48:11.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000018","document":"wf-form4_167718885507722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000018/wf-form4_167718885507722.xml","form_type":"4"}},{"id":2460513,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-12-23T02:17:48.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":13060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 21, 2021, the reporting person filed a Form 4 to report a stock option grant. Due to a clerical error, that grant was shown as covering 13,750 shares. The correct number of shares is 13,060. This amendment reports the correct number of shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On December 21, 2021, the reporting person filed a Form 4 to report a stock option grant. Due to a clerical error, that grant was shown as covering 13,750 shares. The correct number of shares is 13,060. This amendment reports the correct number of shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 21, 2021, the reporting person filed a Form 4 to report a stock option grant. Due to a clerical error, that grant was shown as covering 13,750 shares. The correct number of shares is 13,060. This amendment reports the correct number of shares."}],"balance_after":13060,"derivative":{"exercise_price":15.16,"expiration_date":"2031-12-19","underlying":"Common Stock","underlying_shares":13060},"source":{"system":"sec-edgar","filing":"0001209191-21-071011","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121071011/doc4a.xml","form_type":"4/A","original_submission_date":"2021-12-21"}},{"id":2462015,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-12-21T22:41:09.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on December 20, 2022, subject to the reporting person continuing to provide services to the Issuer through each such vesting date."}],"balance_after":13750,"derivative":{"exercise_price":15.16,"expiration_date":"2031-12-19","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001209191-21-070825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121070825/doc4.xml","form_type":"4"}},{"id":2574353,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-09T20:23:40.000Z","date":"2021-09-08","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in three equal annual installments beginning September 8, 2022."}],"balance_after":44000,"derivative":{"exercise_price":28.32,"expiration_date":"2031-09-07","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001209191-21-055280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121055280/doc4.xml","form_type":"4"}}]}